Statin and Vitamin D Treatment in Patients With Thyroid Eye Disease

Abroad (travel likely)Recruiting

Conditions

Thyroid Eye Disease, TED · Graves Ophthalmopathy

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Taipei Veterans General Hospital, Taipei, Taiwan, Taiwan
Contact: Study coordinator (Chin-Sung Kuo, MD, PhD) · cskuo@vghtpe.gov.tw · 886-2-28757513

Study leads

Chin-Sung Kuo, MD, PhD
Principal Investigator
Taipei Veterans General Hospital, Taipei, Taiwan

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Tofacitinib for Glucocorticoid-Resistant Moderate-to-Severe Thyroid Eye Disease

Thyroid Eye Disease, TED · Graves Ophthalmopathy · Graves Orbitopathy

Abroad (travel likely)RecruitingPHASE2

Xiamen, China

Extension Study of Two Doses of Linsitinib in Subjects With Active, Moderate to Severe Thyroid Eye Disease (TED)

Thyroid Eye Disease · Graves Orbitopathy · Endocrine System Diseases

Abroad (travel likely)RecruitingPHASE2, PHASE3

Miami, United States · Morgantown, United States

A Study of AMG 732 in Healthy Participants and Participants With Thyroid Eye Disease

Thyroid Eye Disease

Abroad (travel likely)RecruitingPHASE1, PHASE2

Little Rock, United States · Newport Beach, United States

A Clinical Study of Cizutamig in Thyroid Eye Disease

Thyroid Eye Disease, TED

Abroad (travel likely)RecruitingPHASE1

Shanghai, China